Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral Ischemia
Open Access
- 21 September 2024
- journal article
- review article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 20 (8) , 2138-2154
Abstract
Ischemic diseases are characterized by obstruction of blood flow to the respective organs, of which ischemia of the heart and brain are the most prominent manifestations with shared pathophysiological mechanisms and risk factors. While most revascularization therapies aim to restore blood flow, this can be challenging due to the limited therapeutic window available for treatment approaches. For a very long time, mesenchymal stromal cells have been used to treat cerebral and cardiac ischemia. However, their application is restricted either by inefficient mode of delivery or the low cell survival rates following implantation into the ischemic microenvironment. Nonetheless, several studies are currently focusing on using of mesenchymal stromal cells engineered to overexpress therapeutic genes as a cell-based gene therapy to restore angiogenesis. This review delves into the utilization of MSCs for angiogenesis and the applications of engineered MSCs for the treatment of cardiac and cerebral ischemia. Moreover, the safety issues related to the genetic modification of MSCs have also been discussed. Graphical AbstractKeywords
Funding Information
- Manipal Academy of Higher Education, Manipal
This publication has 165 references indexed in Scilit:
- Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart FunctionStem Cells, 2007
- Endothelial Cell Migration During AngiogenesisCirculation Research, 2007
- Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBrain, 2006
- A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult ratsBrain Research, 2004
- Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in RatsCirculation Research, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Exosomes: composition, biogenesis and functionNature Reviews Immunology, 2002
- Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in RatsStroke, 2001
- Ischemia: from acidosis to oxidationThe FASEB Journal, 1993